Accelerate Diagnostics’ Shareholder Decisions at Annual Meeting
PremiumCompany AnnouncementsAccelerate Diagnostics’ Shareholder Decisions at Annual Meeting
6M ago
Accelerate Diagnostics reports Q1 EPS (88c)vs. ($1.71) last year
Premium
The Fly
Accelerate Diagnostics reports Q1 EPS (88c)vs. ($1.71) last year
6M ago
Accelerate Diagnostics price target lowered to $1 from $2 at Craig-Hallum
Premium
The Fly
Accelerate Diagnostics price target lowered to $1 from $2 at Craig-Hallum
7M ago
Accelerate Diagnostics price target lowered to $2 from $5 at Craig-Hallum
PremiumThe FlyAccelerate Diagnostics price target lowered to $2 from $5 at Craig-Hallum
10M ago
Accelerate Diagnostics reports preliminary FY23 revenue$12.1M, consensus $12.81M
Premium
The Fly
Accelerate Diagnostics reports preliminary FY23 revenue$12.1M, consensus $12.81M
10M ago
Accelerate Diagnostics files to sell units, no amount given
Premium
The Fly
Accelerate Diagnostics files to sell units, no amount given
11M ago
Accelerate Diagnostics trading resumes
PremiumThe FlyAccelerate Diagnostics trading resumes
1y ago
Accelerate Diagnostics trading halted, volatility trading pause
Premium
The Fly
Accelerate Diagnostics trading halted, volatility trading pause
1y ago
Accelerate Diagnostics announces 1-for-10 reverse stock split
Premium
The Fly
Accelerate Diagnostics announces 1-for-10 reverse stock split
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100